BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16013717)

  • 1. Dosimetry of the 198Au source used in interstitial brachytherapy.
    Dauffy LS; Braby LA; Berner BM
    Med Phys; 2005 Jun; 32(6):1579-88. PubMed ID: 16013717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air-kerma strength determination of a new directional (103)Pd source.
    Aima M; Reed JL; DeWerd LA; Culberson WS
    Med Phys; 2015 Dec; 42(12):7144-52. PubMed ID: 26632069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
    J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed.
    Chiu-Tsao ST; Duckworth TL; Hsiung CY; Li Z; Williamson J; Patel NS; Harrison LB
    Med Phys; 2003 Jul; 30(7):1732-5. PubMed ID: 12906190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo-aided dosimetry of the new Bebig IsoSeed 103Pd interstitial brachytherapy seed.
    Daskalov GM; Williamson JF
    Med Phys; 2001 Oct; 28(10):2154-61. PubMed ID: 11695778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.